Trial
NCT00454324
Study of Abraxane and Carboplatin to Treat Small Cell Lung Cancer
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
UNC Lineberger Comprehensive Cancer Center
Collaborators
Celgene Corporation
Condition
Small Cell Lung Cancer
Intervention
Carboplatin
Why stopped
slow accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-07-11